淋巴管新生
伤口愈合
淋巴系统
医学
淋巴管
淋巴水肿
慢性伤口
血管生成
炎症
血管内皮生长因子C
癌症研究
病理
血管内皮生长因子
转移
血管内皮生长因子A
癌症
免疫学
内科学
血管内皮生长因子受体
乳腺癌
作者
Lorenz M. Brunner,Yuliang He,Nikola Cousin,Jeannette Scholl,Livia K. Albin,B. Schmucki,Sandrin Supersaxo,Gaetana Restivo,Jürg Hafner,Dario Neri,Sabine Werner,Michael J. Detmar
出处
期刊:Cells
[Multidisciplinary Digital Publishing Institute]
日期:2023-02-01
卷期号:12 (3): 472-472
被引量:44
标识
DOI:10.3390/cells12030472
摘要
Chronic wounds represent a major therapeutic challenge. Lymphatic vessel function is impaired in chronic ulcers but the role of lymphangiogenesis in wound healing has remained unclear. We found that lymphatic vessels are largely absent from chronic human wounds as evaluated in patient biopsies. Excisional wound healing studies were conducted using transgenic mice with or without an increased number of cutaneous lymphatic vessels, as well as antibody-mediated inhibition of lymphangiogenesis. We found that a lack of lymphatic vessels mediated a proinflammatory wound microenvironment and delayed wound closure, and that the VEGF-C/VEGFR3 signaling axis is required for wound lymphangiogenesis. Treatment of diabetic mice (db/db mice) with the F8-VEGF-C fusion protein that targets the alternatively spliced extra domain A (EDA) of fibronectin, expressed in remodeling tissue, promoted wound healing, and potently induced wound lymphangiogenesis. The treatment also reduced tissue inflammation and exerted beneficial effects on the wound microenvironment, including myofibroblast density and collagen deposition. These findings indicate that activating the lymphatic vasculature might represent a new therapeutic strategy for treating chronic non-healing wounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI